Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Anti-Meth Caucus

This article was originally published in The Tan Sheet

Executive Summary

Sens. Dianne Feinstein (D-Calif.) and Jim Talent (R-Mo.) are co-chairs of the Senate's new Anti-Meth Caucus, according to an Oct. 7 announcement. The caucus will work with local law enforcement "to push legislation that helps them stay ahead of the meth cooks," Talent says, noting that treatment and prevention will also be targets. Fellow caucus co-chairs are Sens. Joe Biden (D-Del.), Chuck Grassley (R-Iowa.), Kent Conrad (D- N.D.) and Conrad Burns (R-Mont.). Sens. Talent and Feinstein co-sponsored a federal bill that would place pseudoephedrine, a meth precursor, behind pharmacy counters. The Combat Meth Act awaits the approval of a House and Senate Conference Committee, the last step before being signed into law (1"The Tan Sheet" Sept. 12, 2005, p. 5 and 2"The Tan Sheet" Sept. 19, 2005, In Brief)...

You may also be interested in...



Meth Act Passes In Senate Commerce, Justice & Science Appropriations Bill

Unanimous Senate support of the Combat Meth Act, coupled with the bill's attachment to a spending bill, improves the odds for more unified national pseudoephedrine restrictions

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098741

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel